O‐27: Early HCV RNA kinetics predict relapse to sofosbuvir/ribavirin dual therapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2893|22|S2|16-16

ISSN： 1352-0504

Source： JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol.22, Iss.S2, 2015-06, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Haemophilia‐related outcome after liver transplantation and treatment with sofosbuvir/ribavirin in a HCV–HIV coinfected man with liver failure and hepatocellular carcinoma

By  

HAEMOPHILIA, Vol. 21, Iss. 2, 2015-03 ,pp. : e131-e133

John Wiley & Sons Inc

Access to resources Recommend Favorite

HCV Genetic Elements Determining the Early Response to Peginterferon and Ribavirin Therapy

By  

Intervirology, Vol. 53, Iss. 1, 2010-01 ,pp. : 66-69

Karger

Access to resources Recommend Favorite

Directly observed therapy of sofosbuvir/ribavirin +/− peginterferon with minimal monitoring for the treatment of chronic hepatitis C in people with a history of drug use in Chennai, India (C‐DOT)

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 25, Iss. 1, 2018-01 ,pp. : 37-46

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evolution of the HCV viral population from a patient with S282T detected at relapse after sofosbuvir monotherapy

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 11, 2015-11 ,pp. : 871-881

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evolution of the HCV viral population from a patient with S282T detected at relapse after sofosbuvir monotherapy

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 1352-0504, Iss. 11, 2015-11 ,pp. : 871-881

John Wiley & Sons Inc

Access to resources Recommend Favorite